Synergy between Winter Flounder antimicrobial peptides

被引:8
作者
Maria Clarke
Charlotte K. Hind
Philip M. Ferguson
Giorgia Manzo
Bhumil Mistry
Bingkun Yue
Janis Romanopulos
Melanie Clifford
Tam T. Bui
Alex F. Drake
Christian D. Lorenz
J. Mark Sutton
A. James Mason
机构
[1] King’s College London,Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Science
[2] UK Health Security Agency,Technology Development Group
[3] Research and Evaluation,Centre for Biomolecular Spectroscopy and Randall Division of Cell and Molecular Biophysics
[4] King’s College London,Department of Physics
[5] King’s College London,undefined
来源
npj Antimicrobials and Resistance | / 1卷 / 1期
关键词
D O I
10.1038/s44259-023-00010-7
中图分类号
学科分类号
摘要
Some antimicrobial peptides (AMPs) have potent bactericidal activity and are being considered as potential alternatives to classical antibiotics. In response to an infection, such AMPs are often produced in animals alongside other peptides with low or no perceivable antimicrobial activity, whose role is unclear. Here we show that six AMPs from the Winter Flounder (WF) act in synergy against a range of bacterial pathogens and provide mechanistic insights into how this increases the cooperativity of the dose-dependent bactericidal activity and potency that enable therapy. Only two WF AMPs have potent antimicrobial activity when used alone but we find a series of two-way combinations, involving peptides which otherwise have low or no activity, yield potent antimicrobial activity. Weakly active WF AMPs modulate the membrane interactions of the more potent WF AMPs and enable therapy in a model of Acinetobacter baumannii burn wound infection. The observed synergy and emergent behaviour may explain the evolutionary benefits of producing a family of related peptides and are attractive properties to consider when developing AMPs towards clinical applications.
引用
收藏
相关论文
共 96 条
[1]  
Yu G(2016)Combination effects of antimicrobial peptides Antimicrob. Agents Chemother. 60 1717-1724
[2]  
Baeder DY(2018)Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics Proc. Biol. Sci. 285 20172687-117
[3]  
Regoes RR(2017)Antimicrobial peptide exposure selects for J. Antimicrob. Chemother. 72 115-1061
[4]  
Rolff J(2021) resistance to human defence peptides Trends Microbiol. 29 1058-527
[5]  
Yu G(2019)Evolutionary constraints on the acquisition of antimicrobial peptide resistance in bacterial pathogens Nat. Commun. 10 521-1040
[6]  
Baeder DY(1998)Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance Antimicrob. Agents Chemother. 42 1029-12013
[7]  
Regoes RR(2022)Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy Biochemistry 61 12008-364
[8]  
Rolff J(1997)Temporin B forms hetero-oligomers with temporin L, modifies its membrane activity, and increases the cooperativity of its antibacterial pharmacodynamic profile J. Biol. Chem. 272 359-126
[9]  
Kubicek-Sutherland JZ(2002)Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of Winter Flounder Biochim. Biophys. Acta 1564 119-614
[10]  
Jangir PK(2001)Antibacterial peptide pleurocidin forms ion channels in planar lipid bilayers J. Peptide Res. 57 e1004104-1943